Abeona 治疗公司
US ˙ NasdaqCM ˙ US00289Y2063

介绍

本页面提供了有关 Steven H Rouhandeh 已知的内部交易历史的全面分析。内部人士包括公司的高管、董事或重要投资者。一般而言,基于内幕、非公开信息进行交易是非法的。这并不意味着他们在自己的公司进行任何交易都是非法的。但是,他们必须通过Form 4向美国证券交易委员会(SEC)报告所有交易。尽管存在这些限制,学术研究表明,整体而言,内部人士在自己公司中的投资表现往往优于市场。

平均交易盈利能力

“平均交易盈利能力”衡量了内部人士在过去三年中所有非计划性的公开市场买入交易的平均回报率。计算过程包括检查每笔交易,排除了作为10b5-1交易计划的一部分的交易。然后,对每笔交易在3、6和12个月的表现进行平均,以生成该笔交易最终的表现指标。然后,将所有交易的表现指标进行平均,计算出内部人士的总体平均表现指标。列表仅包含在过去两年中进行过至少三笔交易的内部人士。

如果内部人士的交易盈利能力显示为"N/A",则可能是因为该内部人士在过去三年内没有进行任何公开市场买入交易,或者他们进行的交易距离现在时间太近,无法计算出可靠的表现指标。

更新频率:每日

查看收益最高的的内幕交易者列表。

报告内部持仓的公司

美国证券交易委员会(SEC)文件显示Steven H Rouhandeh已报告在以下公司拥有持仓或进行了交易:

证券 职位 最新报告的持仓
US:ABEO / Abeona Therapeutics Inc. Director, 10% Owner 49,084
如何解读这些图表

以下图表显示了在Steven H Rouhandeh进行的每笔公开市场非计划交易后证券的股价表现。非计划交易是指没有作为10b5-1交易计划的一部分而进行的交易。股价表现以累积百分比变化的方式绘制。例如,如果一笔内部人士交易是在2019年1月1日进行的,该图表将显示该证券的每日百分比变化直至当前日期。如果在此期间股价从10美元涨至15美元,则股价的累积百分比变化将为50%。从10美元涨至20美元的价格变化将为100%,而从10美元跌至5美元的价格变化将为-50%。

最终,我们将评估内部人士的交易与股价的超额回报(正向或负向)之间的相关性,以判断内部人士是否在交易中利用内部信息获利。如果内部人士有这样的行为,我们预期看到(a)买入后的正回报,或者(b)卖出后的负回报。对于情况(a),买入图表将显示一系列向上倾斜的曲线,表示每次买入后都有正回报。对于情况(b),卖出图表将显示一系列向下倾斜的曲线,表示每次卖出后都有负回报。

然而,仅凭这一点还不足以得出结论。例如,如果公司的股价在多年内呈现非周期性上升,我们会预期所有买入后的图表都呈现向上倾斜。同样地,多年来呈现非周期性下降的股价会导致卖出后的图表也呈现向下倾斜。这两种情况的图表都不能表示内部人士在进行内幕交易。

最有力的指标是在公司股价呈极度循环波动的情况下,“买入”图表显示正向信号,而“卖出”图表显示负向趋势。这种情况强烈暗示内部人士可能根据内幕信息精确地计时进行交易,以获得财务优势。

ABEO / Abeona Therapeutics Inc.内部人士买入 - 短期收益分析

在这一部分,我们分析了在 ABEO / Abeona Therapeutics Inc. 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报,以及是否值得跟踪。该分析基于每笔交易后一年的情况,结果仅为理论值

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数
报告
价格
经调整
股数
经调整
价格
成本基础 达到最高利润的
天数
达到最高利润时的
价格
最高
利润($)
最高回报率(%)
2014-12-24 PTBI Rouhandeh Steven H 250,000 4.0000 10,000 100.0000 1,000,000 731 4.8000 -952,000 -95.20

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

ABEO / Abeona Therapeutics Inc. Insider Trades
ABEO / Abeona Therapeutics Inc.内部人士卖出 - 短期亏损分析

在这一部分,我们分析了在 ABEO / Abeona Therapeutics Inc. 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式,可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况,

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数
报告
价格
经调整
股数
经调整
价格
成本基础 达到最低利润的
天数
达到最低利润时的
价格
避免的
最高损失金额($)
避免的
最高损失率($)
2020-09-15 ABEO SCO CAPITAL PARTNERS LLC 1,989 2.0017 80 50.0425 3,981 15 1.0200 -3,900 -97.98
2020-09-11 ABEO SCO CAPITAL PARTNERS LLC 4,600 2.0095 184 50.2375 9,244
2020-09-10 ABEO SCO CAPITAL PARTNERS LLC 73,411 2.0771 2,936 51.9275 152,482
2020-08-17 ABEO SCO CAPITAL PARTNERS LLC 80,000 2.8539 3,200 71.3475 228,312

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

ABEO / Abeona Therapeutics Inc. Insider Trades
内幕交易历史

该表格显示了由 Steven H Rouhandeh 进行的所有内幕交易的完整列表,这些交易已向美国证券交易委员会(SEC)披露。

备案日期 交易日期 表格 股票代码 证券 代码 10b5-1 股数 剩余股数 %
变化
每股
股价
交易
金额
剩余
金额
2021-05-27 2021-05-25 4 ABEO ABEONA THERAPEUTICS INC.
Stock Option (right to buy)
A - Award 49,084 49,084
2021-05-27 2021-05-25 4 ABEO ABEONA THERAPEUTICS INC.
Common Stock
A - Award 38,590 533,590 7.80
2021-05-05 2021-05-03 4 ABEO ABEONA THERAPEUTICS INC.
Common Stock
S - Sale X -80,000 11,079,292 -0.72 2.01 -160,888 22,281,564
2021-03-19 2021-03-18 4 ABEO ABEONA THERAPEUTICS INC.
Common Stock
S - Sale X -80,000 11,159,292 -0.71 2.23 -178,624 24,916,467
2021-02-18 2021-02-16 4 ABEO ABEONA THERAPEUTICS INC.
Common Stock
S - Sale X -120,000 11,239,292 -1.06 2.97 -356,808 33,418,911
2021-02-10 2021-02-08 4 ABEO ABEONA THERAPEUTICS INC.
Common Stock
S - Sale X -240,000 11,359,292 -2.07 3.01 -722,832 34,211,916
2021-01-19 2021-01-19 4 ABEO ABEONA THERAPEUTICS INC.
Common Stock
S - Sale X -207,117 11,599,292 -1.75 2.08 -431,218 24,149,726
2021-01-19 2021-01-15 4 ABEO ABEONA THERAPEUTICS INC.
Common Stock
S - Sale X -81,283 11,806,409 -0.68 2.02 -164,086 23,833,598
2021-01-19 2021-01-14 4 ABEO ABEONA THERAPEUTICS INC.
Common Stock
S - Sale X -31,600 11,887,692 -0.27 2.00 -63,213 23,780,139
2020-11-20 2020-11-20 4 ABEO ABEONA THERAPEUTICS INC.
Stock Option (right to buy)
D - Sale to Issuer -80,000 0 -100.00
2020-11-20 2020-11-20 4 ABEO ABEONA THERAPEUTICS INC.
Stock Option (right to buy)
A - Award 80,000 80,000
2020-11-20 2020-11-20 4 ABEO ABEONA THERAPEUTICS INC.
Stock Option (right to buy)
D - Sale to Issuer -125,000 0 -100.00
2020-11-20 2020-11-20 4 ABEO ABEONA THERAPEUTICS INC.
Stock Option (right to buy)
A - Award 125,000 125,000
2020-11-20 2020-11-20 4 ABEO ABEONA THERAPEUTICS INC.
Stock Option (right to buy)
D - Sale to Issuer -200,000 0 -100.00
2020-11-20 2020-11-20 4 ABEO ABEONA THERAPEUTICS INC.
Stock Option (right to buy)
D - Sale to Issuer -200,000 0 -100.00
2020-11-20 2020-11-20 4 ABEO ABEONA THERAPEUTICS INC.
Stock Option (right to buy)
A - Award 200,000 200,000
2020-11-20 2020-11-20 4 ABEO ABEONA THERAPEUTICS INC.
Stock Option (right to buy)
A - Award 200,000 200,000
2020-11-20 2020-11-20 4 ABEO ABEONA THERAPEUTICS INC.
Stock Option (right to buy)
D - Sale to Issuer -120,000 0 -100.00
2020-11-20 2020-11-20 4 ABEO ABEONA THERAPEUTICS INC.
Stock Option (right to buy)
D - Sale to Issuer -120,000 0 -100.00
2020-11-20 2020-11-20 4 ABEO ABEONA THERAPEUTICS INC.
Stock Option (right to buy)
A - Award 120,000 120,000
2020-11-20 2020-11-20 4 ABEO ABEONA THERAPEUTICS INC.
Stock Option (right to buy)
A - Award 120,000 120,000
2020-11-20 2020-11-20 4 ABEO ABEONA THERAPEUTICS INC.
Stock Option (right to buy)
D - Sale to Issuer -153,244 0 -100.00
2020-11-20 2020-11-20 4 ABEO ABEONA THERAPEUTICS INC.
Stock Option (right to buy)
A - Award 153,244 153,244
2020-11-20 2020-11-20 4 ABEO ABEONA THERAPEUTICS INC.
Stock Option (right to buy)
D - Sale to Issuer -86,756 0 -100.00
2020-11-20 2020-11-20 4 ABEO ABEONA THERAPEUTICS INC.
Stock Option (right to buy)
A - Award 86,756 86,756
2020-09-17 2020-09-15 4 ABEO ABEONA THERAPEUTICS INC.
Common Stock
S - Sale -1,989 11,919,292 -0.02 2.00 -3,981 23,858,847
2020-09-14 2020-09-11 4 ABEO ABEONA THERAPEUTICS INC.
Common Stock
S - Sale -4,600 11,921,281 -0.04 2.01 -9,244 23,955,814
2020-09-14 2020-09-10 4 ABEO ABEONA THERAPEUTICS INC.
Common Stock
S - Sale -73,411 11,925,881 -0.61 2.08 -152,482 24,771,247
2020-08-19 2020-08-17 4 ABEO ABEONA THERAPEUTICS INC.
Common Stock
S - Sale -80,000 11,999,292 -0.66 2.85 -228,312 34,244,779
2020-05-22 2020-05-20 4 ABEO ABEONA THERAPEUTICS INC.
Employee Stock Option (right to buy)
A - Award 86,756 86,756
2020-05-22 2020-05-20 4 ABEO ABEONA THERAPEUTICS INC.
Common Stock
A - Award 120,000 495,000 32.00
2020-03-18 2020-03-16 4 ABEO ABEONA THERAPEUTICS INC.
Employee Stock Option (right to buy)
A - Award 153,244 153,244
2019-04-11 2019-04-09 4 ABEO ABEONA THERAPEUTICS INC.
Employee Stock Option (right to buy)
A - Award 120,000 120,000
2017-12-18 2017-12-14 4 ABEO ABEONA THERAPEUTICS INC.
Stock option (right to buy)
A - Award 90,000 90,000
2017-12-18 2017-12-14 4 ABEO ABEONA THERAPEUTICS INC.
Srock option (right to buy)
A - Award 30,000 30,000
2016-12-15 2016-12-13 4 ABEO ABEONA THERAPEUTICS INC.
Stock option (right to buy)
A - Award 150,000 200,000 300.00
2016-12-15 2016-12-13 4 ABEO ABEONA THERAPEUTICS INC.
Stock option (right to buy)
A - Award 50,000 50,000
2016-02-16 2016-02-11 4 ABEO ABEONA THERAPEUTICS INC.
Stock option (right to buy)
A - Award 150,000 200,000 300.00
2016-02-16 2016-02-11 4 ABEO ABEONA THERAPEUTICS INC.
Stock option (right to buy)
A - Award 50,000 50,000
2015-06-19 2015-05-11 4/A ABEO ABEONA THERAPEUTICS INC.
Stock option (right to buy)
A - Award 125,000 125,000
2015-06-19 2015-05-11 4/A ABEO ABEONA THERAPEUTICS INC.
Common stock
A - Award 375,000 375,000
2015-05-13 2015-05-11 4 PTBI PLASMATECH BIOPHARMACEUTICALS INC
Stock option (right to buy)
A - Award 125,000 205,000 156.25 7.34 917,500 1,504,700
2015-05-13 2015-05-11 4 PTBI PLASMATECH BIOPHARMACEUTICALS INC
Common stock
A - Award 375,000 375,000 7.34 2,752,500 2,752,500
2014-12-30 2014-12-24 4/A PTBI PLASMATECH BIOPHARMACEUTICALS INC
Series B Cumlative Convertible Preferred Stock
J - Other -139 0 -100.00 4.00 -554
2014-12-30 2014-12-24 4/A PTBI PLASMATECH BIOPHARMACEUTICALS INC
Series B Cumulative Convertible Preferred Stock
J - Other -861 0 -100.00 4.00 -3,446
2014-12-30 2014-12-24 4/A PTBI PLASMATECH BIOPHARMACEUTICALS INC
Series A Cumulative Convertible Preferred Stock
C - Conversion -154 0 -100.00 4.00 -617
2014-12-30 2014-12-24 4/A PTBI PLASMATECH BIOPHARMACEUTICALS INC
Series A Cumlative Convertible Preferred Stock
C - Conversion -1,969 0 -100.00 4.00 -7,875
2014-12-30 2014-12-24 4/A PTBI PLASMATECH BIOPHARMACEUTICALS INC
Common Stock Purchase Warrants
P - Purchase 250,000 250,000 0.01 2,500 2,500
2014-12-30 2014-12-24 4/A PTBI PLASMATECH BIOPHARMACEUTICALS INC
Common Stock
J - Other 216,718 1,364,195 18.89 4.00 866,872 5,456,780
2014-12-30 2014-12-24 4/A PTBI PLASMATECH BIOPHARMACEUTICALS INC
Common Stock
J - Other 1,703,362 12,079,291 16.42 4.00 6,813,448 48,317,164
2014-12-30 2014-12-24 4/A PTBI PLASMATECH BIOPHARMACEUTICALS INC
Common Stock
J - Other 693,051 1,147,477 152.51 4.00 2,772,204 4,589,908
2014-12-30 2014-12-24 4/A PTBI PLASMATECH BIOPHARMACEUTICALS INC
Common Stock
J - Other 4,306,950 10,375,930 70.97 4.00 17,227,800 41,503,720
2014-12-30 2014-12-24 4/A PTBI PLASMATECH BIOPHARMACEUTICALS INC
Common Stock
C - Conversion 65,280 454,427 16.78 4.00 261,120 1,817,708
2014-12-30 2014-12-24 4/A PTBI PLASMATECH BIOPHARMACEUTICALS INC
Common Stock
C - Conversion 831,836 6,068,980 15.88 4.00 3,327,344 24,275,920
2014-12-30 2014-12-24 4/A PTBI PLASMATECH BIOPHARMACEUTICALS INC
Common Stock
C - Conversion 385,725 389,147 11,271.92 4.00 1,542,900 1,556,588
2014-12-30 2014-12-24 4/A PTBI PLASMATECH BIOPHARMACEUTICALS INC
Common Stock
C - Conversion 4,922,102 5,237,144 1,562.36 4.00 19,688,408 20,948,576
2014-12-30 2014-12-24 4/A PTBI PLASMATECH BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 250,000 315,042 384.37 4.00 1,000,000 1,260,168
2014-12-29 2014-12-24 4 PTBI PLASMATECH BIOPHARMACEUTICALS INC
Series B Cumulative Convertible Preferred Stock
J - Other -139 0 -100.00 4.00 -554
2014-12-29 2014-12-24 4 PTBI PLASMATECH BIOPHARMACEUTICALS INC
Series B Cumulative Convertible Preferred Stock
J - Other -861 0 -100.00 4.00 -3,446
2014-12-29 2014-12-24 4 PTBI PLASMATECH BIOPHARMACEUTICALS INC
Series A Cumulative Convertible Preferred Stock
C - Conversion -154 0 -100.00 4.00 -617
2014-12-29 2014-12-24 4 PTBI PLASMATECH BIOPHARMACEUTICALS INC
Series A Cumulative Convertible Preferred Stock
C - Conversion -1,969 0 -100.00 4.00 -7,875
2014-12-29 2014-12-24 4 PTBI PLASMATECH BIOPHARMACEUTICALS INC
Common Stock Purchase Warrants
P - Purchase 250,000 702,195 55.29 0.01 2,500 7,022
2014-12-29 2014-12-24 4 PTBI PLASMATECH BIOPHARMACEUTICALS INC
Common Stock
J - Other 216,718 1,364,195 18.89 4.00 866,872 5,456,780
2014-12-29 2014-12-24 4 PTBI PLASMATECH BIOPHARMACEUTICALS INC
Common Stock
J - Other 1,703,362 12,080,463 16.41 4.00 6,813,448 48,321,852
2014-12-29 2014-12-24 4 PTBI PLASMATECH BIOPHARMACEUTICALS INC
Common Stock
J - Other 693,051 1,147,477 152.51 4.00 2,772,204 4,589,908
2014-12-29 2014-12-24 4 PTBI PLASMATECH BIOPHARMACEUTICALS INC
Common Stock
J - Other 4,306,950 10,377,102 70.95 4.00 17,227,800 41,508,408
2014-12-29 2014-12-24 4 PTBI PLASMATECH BIOPHARMACEUTICALS INC
Common Stock
C - Conversion 65,280 454,427 16.78 4.00 261,120 1,817,708
2014-12-29 2014-12-24 4 PTBI PLASMATECH BIOPHARMACEUTICALS INC
Common Stock
C - Conversion 831,836 6,070,152 15.88 4.00 3,327,344 24,280,608
2014-12-29 2014-12-24 4 PTBI PLASMATECH BIOPHARMACEUTICALS INC
Common Stock
C - Conversion 385,725 389,147 11,271.92 4.00 1,542,900 1,556,588
2014-12-29 2014-12-24 4 PTBI PLASMATECH BIOPHARMACEUTICALS INC
Common Stock
C - Conversion 4,922,102 5,238,316 1,556.57 4.00 19,688,408 20,953,264
2014-12-29 2014-12-24 4 PTBI PLASMATECH BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 250,000 316,214 377.56 4.00 1,000,000 1,264,856
2014-03-11 2014-03-07 4 accp ACCESS PHARMACEUTICALS INC
Stock option (right to buy)
A - Award 3,000,000 4,000,000 300.00 0.37 1,110,000 1,480,000
2014-03-11 2014-03-07 4 accp ACCESS PHARMACEUTICALS INC
Stock option (right to buy)
A - Award 1,000,000 1,000,000 0.37 370,000 370,000
2012-12-20 2012-12-19 4 accp ACCESS PHARMACEUTICALS INC
Common Stock Purchase Warrants
G - Gift 1,366,202 2,772,202 97.17
2012-12-20 2012-12-19 4 accp ACCESS PHARMACEUTICALS INC
Common Stock Purchase Warrants
G - Gift -1,366,202 17,227,798 -7.35
2012-12-20 2012-12-19 4 accp ACCESS PHARMACEUTICALS INC
Series B Cumulative Convertible Preferred Stock
G - Gift 68 139 97.17 10,000.00 683,101 1,386,101
2012-12-20 2012-12-19 4 accp ACCESS PHARMACEUTICALS INC
Series B Cumulative Convertible Preferred Stock
G - Gift -68 861 -7.35 10,000.00 -683,101 8,613,899
2012-10-26 2012-10-25 4 accp ACCESS PHARMACEUTICALS INC
Common Stock Purchase Warrants
P - Purchase 1,406,000 1,406,000
2012-10-26 2012-10-25 4 accp ACCESS PHARMACEUTICALS INC
Common Stock Purchase Warrants
P - Purchase 18,594,000 18,594,000
2012-10-26 2012-10-25 4 accp ACCESS PHARMACEUTICALS INC
Series B Cumulative Convertible Preferred Stock
P - Purchase 70 70 10,000.00 703,000 703,000
2012-10-26 2012-10-25 4 accp ACCESS PHARMACEUTICALS INC
Series B Cumulative Convertible Preferred Stock
P - Purchase 930 930 10,000.00 9,297,000 9,297,000
P
非衍生或衍生证券的公开市场或私下买入
S
非衍生或衍生证券的公开市场或私下卖出
A
公司向内部人员授予、奖励或以其他方式获取证券(例如股票期权)
C
衍生工具转换
D
将证券卖出或转让回公司
F
使用从公司收到的证券的一部分来支付行使价或税务负担。
G
内部人士赠送或接收他人赠送公司股票
K
股权掉期和类似的避险交易
M
行使或转换从公司获得的衍生证券(例如期权)
V
内部人士通过Form 4自愿报告的一笔交易
J
其他(附有交易描述的脚注)